Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
Fronkova E, Mejstrikova E, Avigad S, Chik KW, Castillo L, Manor S, Reznickova L, Valova T, Zdrahalova K, Hrusak O, Jabali Y, Schrappe M, Conter V, Izraeli S, Li CK, Stark B, Stary J, Trka J.
Fronkova E, et al. Among authors: trka j.
Leukemia. 2008 May;22(5):989-97. doi: 10.1038/leu.2008.22. Epub 2008 Feb 28.
Leukemia. 2008.
PMID: 18305563
Clinical Trial.